Introduction
============

The gingiva is the component of the periodontium covering the tooth-bearing alveolar bone and the necks of the teeth. One of its eminent characteristics is its remarkable wound healing and regenerative capacity, with rapid reconstitution of the tissue architecture showing little, if any, evidence of scarring.^[@bib1]^ The multiple functions of gingival fibroblasts, their variable responsiveness to growth factors and their ability to produce specific extracellular matrix proteins during the healing process demonstrate that they represent a heterogeneous population of cells.^[@bib2],[@bib3],[@bib4],[@bib5],[@bib6]^ These properties also indicate the presence of a population of stem/progenitor cells, similar to other periodontal components, which gives rise to these heterogeneous cells.

Representing a key component of the periodontium, the free gingival margin has a unique developmental origin, arising from the outer layer of the dental follicle, the perifollicular mesenchyme,^[@bib7]^ as well as partly from the inner layer of the dental follicle, the dental follicle proper,^[@bib8]^ from which stem/progenitor cells have been isolated.^[@bib9]^ In addition, the free gingival margin partially arises from the periodontal ligament cells,^[@bib2]^ which themselves originate from the dental follicle proper;^[@bib7]^ periodontal ligament stem/progenitor cells have also been obtained from this tissue^[@bib10]^ ([Figure 1a](#fig1){ref-type="fig"}). In a recent study, porcine free gingival margin-derived stem/progenitor cells, that were isolated via a minimally invasive procedure and magnetically sorted using anti-STRO-1 antibodies, demonstrated remarkable periodontal regenerative capacity *in vivo*.^[@bib11]^ This finding clearly challenged the classical compartmentalisation theory declaring that the gingival connective tissue does not contribute to periodontal regeneration and that it should be excluded during guided tissue regeneration (GTR) techniques,^[@bib12]^ instead showing that this tissue harbours multipotent stem/progenitor cells with remarkable regenerative potential. As a second-stage study, the aim of the present study was to perform *in vitro* characterisation and comparison of the stem/progenitor cell characteristics of magnetically sorted STRO-1-positive (magnetic activated cell sorting (MACS)^+^) and -negative (MACS^−^) cell fractions isolated from the human free gingival margin.

Material and methods
====================

Isolation and culture of the tissues
------------------------------------

After obtaining informed consent from patients (IRB Approval number D 444/10), healthy, partially impacted third molar teeth with free gingival soft tissue collars were surgically removed from six individuals (*n*=6) at the Department of Oral Surgery of the Christian Albrechts University, Kiel, Germany. The free gingival tissue collars were detached ([Figure 1b](#fig1){ref-type="fig"}, dotted incision line), de-epithelized under magnification, cut into small pieces (approximately 2 mm×2 mm), rinsed several times with Eagle\'s minimum essential medium alpha modification (Sigma-Aldrich GmbH, Hamburg, Germany) supplemented with antibiotics (100 U⋅mL^−1^ penicillin, 100 µg⋅mL^−1^ streptomycin) and 1% amphotericin (all from Biochrom, Berlin, Germany) and placed into dry 75 mL culture flasks (Sarstedt, Nümbrecht, Germany) for 30 min to allow them to adhere to the bottoms of the flasks. Subsequently, the basic medium, consisting of Eagle\'s minimum essential medium alpha modification supplemented with 15% foetal calf serum (HyClone, Logan, UT, USA), 400 mmol⋅mL^−1^ *L*-glutamine (Biochrom, Berlin, Germany), 100 U⋅mL^−1^ penicillin, 100 µg⋅mL^−1^ streptomycin and 1% amphotericin, was carefully added. The flasks were incubated in 5% carbon dioxide at 37 °C, and the cells were allowed to grow. The culture flasks were periodically checked using phase contrast inverted microscopy, and the basic medium was changed three times per week.

After reaching 80%--85% confluence, the cells were washed with 5 mL phosphate-buffered saline (PBS) (Biochrom, Berlin, Germany). Two millilitres of 0.10% trypsin-ethylenediaminetetraacetic acid (EDTA) (Biochrom, Berlin, Germany) was added, and the culture flasks were incubated for 1 min to detach the cells. Subsequently, 5 mL of the basic medium was added. The medium containing the cells was transferred to sterile Falcon 50 mL polypropylene conical tubes (Becton Dickinson, Heidelberg, Germany) and centrifuged at 2 000*g* for 10 min. The supernatant was discarded, and the cells were re-suspended in 2 ml of the basic medium. The cells were counted and tested for viability using Trypan Blue (Sigma-Aldrich GmbH, Hamburg, Germany) and were finally seeded in basic medium at a density of 30 cells⋅cm^−2^ in 75 mL culture flasks; the flasks were incubated in 5% carbon dioxide at 37 °C.

Fluorescein diacetate--propidium iodide staining
------------------------------------------------

To determine the viability of the seeded cells, fluorescein diacetate--propidium iodide) staining was used. Briefly, stock solutions of fluorescein diacetate (5 mg⋅mL^−1^ in acetone) and propidium iodide (0.02 mg⋅mL^−1^ in Dulbecco\'s PBS) were stored at 4 °C in the dark. Staining was performed by adding a solution containing 2 mg of fluorescein diacetate and 0.6 mg of propidium iodide to the cells and allowing them to stand for 3 min. The cell viability of was investigated using a fluorescence microscope with 520 nm and 590 nm filters.

Immunomagnetic cell sorting
---------------------------

After the first-passage cells reached 80%--85% confluence, they were subjected to immunomagnetic cell sorting using STRO-1 (BioLegend, San Diego, CA, USA) and anti-IgM MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturers\' instructions (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). The positive (MACS^+^ cells) and the negative (MACS^−^ cells) sorted cell fractions were seeded in basic medium in new 75 mL flasks at a density of 30 cells⋅cm^−2^.

Flow cytometric analysis
------------------------

After reaching confluence, samples from second-passage MACS^+^ cells and second-passage MACS^−^ cells were characterized by flow cytometry using antibodies specific for CD14, CD34, CD45, CD73, CD90 and CD105 (all from Becton Dickinson, Heidelberg, Germany), CD146/MUC18 (eBioscience, NatuTec, Frankfurt, Germany) and STRO-1 (BioLegend, San Diego, CA, USA). The binding of the primary antibodies and the corresponding isotype controls was performed according to standard protocols using FcR Blocking Reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) and was evaluated with FACSCalibur E6370 and FACSComp 5.1.1 software (Becton Dickinson, Heidelberg, Germany).

Colony-forming unit assay
-------------------------

To assess their colony-forming efficiency, MACS^+^ cells were cultured in basic medium at a density of 1.63 cells⋅cm^−1^. Aggregates of 50 or more cells were scored as colonies. As controls, MACS^−^ cells were cultured under the same conditions. On the twelfth day, the cultures were fixed with 4% formalin and stained with 0.1% crystal violet, and the numbers of colonies were statistically evaluated.

Multilineage differentiation potential
--------------------------------------

### Osteogenic differentiation

To test for osteogenic differentiation potential, third-passage MACS^+^ cells and third-passage MACS^−^ cells were cultured on six-well culture plates in osteogenic inductive medium (PromoCell, Heidelberg, Germany) at a density of 2×10^4^ cells per well. As controls, MACS^+^ cells and MACS^−^ cells were cultured in basic medium. The media were renewed three times per week. At day 14, the cell cultures were stained with Alizarin Red (Sigma-Aldrich GmbH, Hamburg, Germany)^[@bib13]^ to label calcified deposits, while the expression of runt-related-transcription-factor-2 (Cbfa1/Runx2) and alkaline phosphatase (ALP) was assessed using real-time polymerase chain reaction (PCR; LightCycler; Roche Molecular Biochemicals, Indianapolis, IN, USA).

### Adipogenic differentiation

To test the adipogenic differentiation potential, third-passage MACS^+^ cells and third-passage MACS^−^ cells were cultured on six-well culture plates in adipogenic inductive medium (PromoCell, Heidelberg, Germany) at a density of 3×10^5^ cells per well. As controls, MACS^+^ cells and MACS^−^ cells were cultured in basic medium. The media were renewed three times per week. The presence of lipid drops was evaluated by staining the cells with Oil Red O (Sigma-Aldrich GmbH, Hamburg, Germany),^[@bib13]^ and the expression of peroxisome proliferator-activated receptor gamma (PPAR-γ an early adipogenic marker) and lipoproteinlipase (LPL; a late adipogenic marker) was assessed by PCR at day 21.^[@bib14]^

### Chondrogenic differentiation

To test the chondrogenic differentiation potential, third-passage MACS^+^ cells and third-passage MACS^−^ cells were incubated with chondrogenic inductive medium (PromoCell, Heidelberg, Germany) in 1.5 mL Eppendorf tubes (Eppendorf, Hamburg, Germany) at a density of 3×10^4^ cells per tube. As controls, MACS^+^ cells and MACS^−^ cells were cultured in basic medium. The media were renewed three times per week. Chondrogenic differentiation was evaluated at day 35 by staining glycosaminoglycans with Alcian Blue (Sigma-Aldrich GmbH, Hamburg, Germany)^[@bib13]^ and by testing for the expression of aggrecan (ACAN), also known as cartilage-specific proteoglycan core protein.

RNA extraction and cDNA synthesis
---------------------------------

RNA extraction was performed on MACS^+^ cells and MACS^−^ cells using an RNeasy kit (Qiagen, Hilden, Germany) according to the manufacturer\'s instructions. The obtained RNA was purified using RNase-free-DNase (Promega, Mannheim, Germany) and quantified photometrically. Complementary cDNA was synthesized from 1--13 µL of RNA (1 µg⋅μL^−1^) by reverse transcription using a SuperScript reverse transcription kit (Qiagen, Hilden, Germany) according to the manufacturer\'s instructions (Mastercycler gradient; Eppendorf, Hamburg, Germany). Real-time PCR (LightCycler; Roche Molecular Biochemicals, Indianapolis, IN, USA) was performed as previously described^[@bib15]^ using the primers in [Table 1](#tbl1){ref-type="table"}.

Statistical analysis
--------------------

The Shapiro--Wilk test was used to evaluate the normality of the data distribution. Differences in colony-forming unit (CFU) counts and in the mRNA expression of all tested genes between the MACS^+^ and MACS^−^ cells were examined using the nonparametric Mann--Whitney test with SPSS software (SPSS version 11.5; SPSS, Chicago, IL, USA). The level of significance was set at *P*=0.05.

Results
=======

Phase contrast inverted microscopy and fluorescein diacetate--propidium iodide staining
---------------------------------------------------------------------------------------

Following the initial adherence phase, cells grew out of the gingival tissue masses ([Figure 1c](#fig1){ref-type="fig"}). Cells formed adherent fibroblast-like clusters ([Figure 1d](#fig1){ref-type="fig"}) and were viable when tested with fluorescein diacetate--propidium iodide staining ([Figure 1e](#fig1){ref-type="fig"}).

Colony formation
----------------

Twelve days after seeding, CFUs were observed in the MACS^+^ cell cultures ([Figure 1f and 1g](#fig1){ref-type="fig"}). In contrast, MACS^−^ cells seeded under the same culture conditions showed a more diffuse distribution ([Figure 1h and 1i](#fig1){ref-type="fig"}). The number of CFUs was significantly higher in the MACS^+^ cell cultures, with a median of 5 CFUs per 20 MACS^+^ cells seeded, than in the MACS^−^ cell cultures (*P*\<0.01; Mann--Whitney, [Figure 1j](#fig1){ref-type="fig"}).

Flow cytometric analysis
------------------------

MACS^+^ cells were negative for CD14, CD34 and CD45 and positive for CD73, CD90, CD105, CD146/MUC18 and STRO-1. The expression of CD73, CD90 and CD105 was above 95% ([Figure 1k](#fig1){ref-type="fig"}). MACS^−^ cells showed almost no expression of CD14 and STRO-1, \>95% expression of CD73, CD90 and CD146/MUC18 in addition to the positive expression of the haematopoietic markers CD34, CD45 and CD105 ([Figure 1l](#fig1){ref-type="fig"}).

Multilineage differentiation potential
--------------------------------------

Osteogenic differentiation of MACS^+^ cells was demonstrated by the formation of calcified deposits labelled with Alizarin Red and by the significantly higher expression of Cbfa1/Runx2 (*P*\<0.05; Mann--Whitney) and ALP (*P*\<0.01; Mann--Whitney) than in the controls ([Figure 2a--d](#fig2){ref-type="fig"}). Adipogenic differentiation of MACS^+^ cells resulted in the formation of lipid droplets that were positively stained with Oil Red O and in the significantly higher expression of PPAR-γ (*P*\<0.01; Mann--Whitney) and LPL (*P*\<0.01; Mann--Whitney) than in the controls ([Figure 2e--h](#fig2){ref-type="fig"}). Chondrogenic differentiation of MACS^+^ cells resulted in the formation of glycosaminoglycans positively stained with Alcian Blue and in the higher expression of ACAN (*P*\<0.05; Mann--Whitney), than in the controls ([Figure 2i--k](#fig2){ref-type="fig"}). MACS^−^ cells showed no Alizarin Red-positive deposits and a low level of expression of ALP (*P*\<0.05; Mann--Whitney, [Figure 2l--o](#fig2){ref-type="fig"}). Adipogenic differentiation was not evident in MACS^−^ cells ([Figure 2p--s](#fig2){ref-type="fig"}). Chondrogenic differentiation of MACS^−^ cells was not demonstrated, as was evident by the lack of expression of the cartilage-specific proteoglycan core protein ACAN. MACS^−^ cells and their controls (in sharp contrast to MACS^+^ cell controls) showed uniform staining of glycosaminoglycans ([Figure 2t--v](#fig2){ref-type="fig"}). Chondrogenic lacuna-like structures visible in the stimulated MACS^+^ cells ([Figure 2i](#fig2){ref-type="fig"}) were absent from the stimulated MACS^−^ cells ([Figure 2t](#fig2){ref-type="fig"}).

Gene expression profile
-----------------------

In general, early osteogenic markers such as collagens I and III were more highly expressed than were osteopontin and osteonectin in both cell populations. MACS^+^ cells tended to show higher expression of early osteogenic markers such as ALP, with significantly different levels reached for collagens I (*P*\<0.05) and III^[@bib16]^ (*P*\<0.01). MACS^−^ cells showed a tendency towards higher expression of late osteogenic markers such as osteonectin (*P*\<0.05) and osteopontin, and the expression of collagens I and III and of ALP was lower than in MACS^+^ cells ([Figure 3](#fig3){ref-type="fig"}).

Discussion
==========

The free gingival margin constitutes a distinctive, as well as a pivotal, component of the human periodontium in both developmental and anatomical terms. This tissue is widely available for use and is routinely removed during dental crown lengthening and periodontal surgical procedures. In a recent study, porcine free gingival margin-derived STRO-1/MACS^+^ stem/progenitor cells isolated via a minimally invasive procedure were tested and demonstrated remarkable periodontal regenerative capacity *in vivo*.^[@bib11]^ The aim of the present study was to perform *in vitro* characterisation and comparison of the stem/progenitor cell characteristics of the MACS^+^ and MACS^−^ cell populations of the human free gingival margin.

Recent investigations of gingival stem/progenitor cells demonstrated their many promising qualities for tissue engineering, including an immunomodulatory property,^[@bib17]^ as well as compatibility with alginate hydrogel microbead scaffolds.^[@bib18]^ Earlier studies reported the isolation of progenitor cells from oral soft tissues,^[@bib19]^ including the rugae and incisive papillae of the palate,^[@bib20]^ the maxillary tuberosity,^[@bib21]^ the oral mucosa,^[@bib22]^ the whole,^[@bib23]^ the attached gingiva^[@bib24],[@bib25],[@bib26]^ and hyperplastic gingiva.^[@bib27]^ Along with the difference in anatomical location, the free gingival margin partly differs in its developmental origin from the previously described soft tissue sources. In addition to a common neural crest ectomesenchymal origin lined by ectoderm for all oral soft tissues, the inner layer of the dental follicle, the dental follicle proper,^[@bib8]^ the outer layer of the dental follicle, the perifollicular mesenchyme^[@bib7]^ and the periodontal ligament cells^2^ are suggested to participate in the development of the gingival connective tissues at the free gingival margin of the tooth, unlike the non-tooth-bearing soft tissues of the oral cavity, which are anatomically devoid of dental follicle and periodontal cells. Developmentally, upon tooth eruption, the lamina propria of the free gingival margin is thought to be formed from cells stemming from the outer layer of the dental follicle.^[@bib7]^ Nevertheless, earlier studies demonstrated the presence of fibroblasts stemming from the inner layer of the dental follicle in the free gingival lamina propria at the cemento-enamel junction^[@bib8]^ and further suggested that the dentogingival fibre system originates in part from periodontal ligament cells.^[@bib2]^ The developmental contribution provided by the dental follicle proper and the periodontal ligament cells to the perifollicular mesenchyme accounts for the anatomical distinctiveness of the free gingival margin from the previously investigated oral soft tissues.

Similar to the first-stage *in vivo* study,^[@bib11]^ the putative stem cell marker STRO-1, which was implemented to isolate and purify bone marrow stromal stem cells^[@bib28]^ and alveolar bone proper-derived stem/progenitor cells^[@bib29]^ using immunomagnetic cell selection, was used in the current study to isolate multipotent postnatal stem/progenitor cells (MACS^+^ cells) from heterogeneous gingival connective tissue cells (MACS^−^ cells). This was based on the fact that the latter, in contrast to the targeted multipotent stem/progenitor cells, do not express the distinctive STRO-1 stem/progenitor cell marker.

The MACS^+^ cell fraction showed all of the previously defined classical characteristics of multipotent postnatal stem/progenitor cells.^[@bib13],[@bib30],[@bib31]^ Regarding the surface marker expression profile, the results showed that MACS^+^ cells were positive for CD73, CD90, CD105 (all above 95%), CD146/MUC18 and STRO-1, and negative for CD14, CD45 and CD45, in accord with the marker expression profile defined for multipotent stromal cells in the International Society for Cellular Therapy position statement.^[@bib13]^ The level of STRO-1 expression was comparable to that observed in the porcine cells in the in vivo study.^[@bib32]^ The decrease in the level of STRO-1 expression after the magnetic sorting step has been previously described^[@bib29],[@bib33]^ and suggests a possible downregulation of the 'second tier\'^[@bib33]^ surface marker STRO-1 during the cells\' time in culture^[@bib34]^ before they reach confluence and attain an adequate cell count to be submitted to flow cytometric analysis. Despite this decrease in expression during culture, the employment of the STRO-1/MACS^+^ technique resulted in the selection of MACS^+^ cells that showed all of the 'first tier\'^[@bib33]^ stem/progenitor cell surface markers noted in the International Society for Cellular Therapy\'s predefined percentages and constellation.^[@bib13]^ The selected MACS^+^ cells demonstrated remarkable CFU capacity and showed multilineage differentiation potential, which was evident by their differentiation along the osteogenic, adipogenic and chondrogenic lineages. Finally, unstimulated MACS^+^ cells expressed all of the tested markers for mineralized tissue.

In contrast, the MACS^−^ cells lacked many of the predefined stem/progenitor cell characteristics,^[@bib13],[@bib30],[@bib31]^ with a different surface marker expression profile from MACS^+^ cells and almost no expression of CD14 and STRO-1, \>95% expression of CD73, CD90 and CD146/MUC18, positive expression of the haematopoietic markers CD34 and CD45, which are not normally expressed in mesenchymal stem/progenitor cells, and CD105 expression below the predefined cutoff of 95%.^[@bib13]^ No multilineage differentiation potential was evident in MACS^−^ cells apart from an up-regulation of ALP mRNA expression following osteogenic induction. The uniform staining of glycosaminoglycans observed in the cultures of chondrogenically stimulated MACS^−^ cells and their controls (in sharp contrast to the MACS^+^ cell controls) demonstrates the fact that MACS^−^ cells harbour the differentiated/committed population of gingival connective tissue cells, which normally lay down glycosaminoglycans (which stain positive for Alcian Blue) as a part of their normal gingival extracellular connective tissue matrix production. This positive staining further underlines the fact that the MACS^+^ cell controls harboured undifferentiated stem/progenitor cells that were unable to lay down extracellular glycosaminoglycan matrix components in the basic medium. Chondrogenic lacunae-like structures evident in the stimulated MACS^+^ cells were absent from the stimulated MACS^−^ cells. Expression of the cartilage-specific proteoglycan core protein ACAN was also absent from the MACS^−^ cells.

The common standard markers for mineralized tissue, which are usually used as hallmarks for the identification of multipotent postnatal stem/progenitor cells, including adipose-derived stromal cells^[@bib35]^ and bone marrow stromal stem cells,^[@bib36]^ were assessed for in the human free gingival margin-derived stem/progenitor cells. Indeed, in the present study, both the free gingival margin-derived stem/progenitor cells (MACS^+^ cells) and the gingival connective tissue cells (MACS^−^ cells) expressed transcripts encoding most of the tested mineralized tissue markers, albeit in different quantities.

In line with their gingival origin, collagen types I and III were expressed at substantially higher levels in both MACS^+^ and MACS^−^ cells than were osteonectin and osteopontin.^[@bib31],[@bib32]^ Significantly higher levels of collagen types I and III were expressed in MACS^+^ cells than in MACS^−^ cells, along with a tendency to express more ALP. Osteonectin, although minimally expressed in both cell types, was expressed at higher levels in MACS^−^ cells. This is in accord with the results of earlier studies that reported low expression of osteonectin^[@bib37],[@bib38]^ and osteopontin^[@bib33]^ in mature gingival connective tissue. The elevated expression of the late markers osteopontin and osteonectin by the MACS^−^ cells could be considered an indicator of their more differentiated/committed cellular states^[@bib39],[@bib40],[@bib41]^. These findings are consistent with those of earlier studies on mesenchymal stem/progenitor cells and the relationship of their temporal expression of mineralized tissue markers to their cellular developmental process. In terms of matrix synthesis, immature cells are expected to express high levels of early mineralized tissue markers, such as collagen. When the expression of most of the early markers, including collagen, decreases, then the expression of late osteogenic markers increases, denoting a shift from an immature to a more differentiated/committed cellular state^[@bib39],[@bib40],[@bib41]^. In this context, the difference in mineralized tissue marker expression between the immature free gingival margin-derived stem/progenitor cells (MACS^+^ cells) and the more differentiated/committed gingival connective tissue cells (MACS^−^ cells) can be explained. Whether a time-dependent quantification of the shift in the marker expression profile could be clinically employed to indicate the developmental stage of gingival/periodontal cells remains a very interesting point to be investigated.

Conclusion
==========

The human free gingival margin provides a readily accessible and renewable source of multipotent postnatal stem/progenitor cells that can easily be obtained for cellular approaches for periodontal and other tissues\' regeneration. The present results demonstrate that the MACS^+^ cell population, in contrast to the MACS^−^ population, harbours cells with stem/progenitor cell characteristics, and validate the effectiveness of the STRO-1/MACS^+^ technique for the isolation of free gingival stem/progenitor cells.

The authors would like to thank Mrs Mojgan Paymard-Stolz, Mrs Regina Marquat, Mrs Hebke Hinz and Mrs Kerstin Marx for their excellent technical assistance. The study was supported in part by a scholarship from the German-Academic-Exchange-Service (DAAD).

![**Schema of free gingival margin development, CFU assay, and flow cytometric analysis of the surface marker expression profile of the gingival marginderived cells.** **(a)** Schema of free gingival margin development. **(b)** Schema of free gingival margin cell isolation. Microscopic appearance and colony formation: **(c)** phase contrast microscopic appearance of the adherent tissue mass with outgrowing cells (first week) and **(d)** after the first cell passage. **(e)** Viability staining using fluorescein diacetate--propidium iodide. The green colour indicates living cells, and the dead cells are labelled in red. **(f)** CFUs of MACS^+^ cells (arrows, crystal violet). **(g)** Phase contrast microscopic appearance of the MACS^+^ cells (crystal violet). **(h)** Scattered appearance of the MACS^−^ cells (crystal violet) and **(i)** phase contrast microscopic appearance of the MACS^−^ cells (crystal violet). **(j)** CFU assay of MACS^+^ and MACS^−^ cells (box-and-whisker plots with medians and quartiles). Significant differences are marked with asterisks (*n*=6, \*\**P*\<0.01; Mann--Whitney). **(k)** Flow cytometric analysis of the surface marker expression profile of the MACS^+^ cells. **(l)** Flow cytometric analysis of the surface marker expression profile of the MACS^−^ cells. CEJ, cemento-enamel junction; CFU, colony-forming unit; MACS, magnetic activated cell sorting.](ijos201441f1){#fig1}

![**Multilineage differentiation potential of MACS^+^ cells and MACS^−^ cells.** Alizarin Red staining of the osteogenically stimulated MACS^+^ cells (**a**) and their controls (**b**). Cbfa1/Runx2 (**c**) and ALP (**d**) expression in stimulated and unstimulated MACS^+^ cells (box-and-whisker plots with medians and quartiles). Oil Red O staining of the adipogenically stimulated MACS^+^ cells (**e**) and their controls (**f**). PPAR-γ (**g**) and LPL (**h**) expression in stimulated and unstimulated MACS^+^ cells (box-and-whisker plots with medians and quartiles). Alcian Blue staining of the chondrogenically stimulated MACS^+^ cells (**i**) and their controls (**j**). ACAN (**k**) expression in stimulated and unstimulated MACS^+^ cells. Alizarin Red staining of the osteogenically stimulated MACS^−^ cells (**l**) and their controls (**m**). Cbfa1/Runx2 (**n**) and ALP (**o**) expression in stimulated and unstimulated MACS^−^ cells (box-and-whisker plots with medians and quartiles). Oil Red O staining of the adipogenically stimulated MACS^−^ cells (**p**) and their controls (**q**). PPAR-γ (**r**) and LPL (**s**) expression in stimulated and unstimulated MACS^−^ cells (box-and-whisker plots with medians and quartiles). Alcian Blue staining of the chondrogenically stimulated MACS^−^ cells (**t**) and their controls (**u**). ACAN (**v**) expression in stimulated and unstimulated MACS^−^ cells (box-and-whisker plots with medians and quartiles). Significant differences are marked with asterisks (*n*=6, \**P*\<0.05, \*\**P*\<0.01; Mann--Whitney). ACAN, aggrecan; ALP, alkaline phosphatase; Cbfa1/Runx2, runt-related-transcription-factor-2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LPL, lipoproteinlipase; MACS, magnetic activated cell sorting; PPAR-γ, peroxisome proliferator-activated receptor gamma.](ijos201441f2){#fig2}

![**Expression profile of osteogenic markers.** mRNA expression profiles for collagen I, collagen III, alkaline phosphatase, osteonectin and osteopontin (box-and-whisker plots with medians and quartiles) in MACS^+^ and MACS^−^ cells. Significant differences are marked with asterisks (*n*=6, \**P*\<0.05, \*\**P*\<0.01; Mann--Whitney). GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MACS, magnetic activated cell sorting.](ijos201441f3){#fig3}

###### Primer sequences used for real-time PCR

  Gene                    GenBank accession number         Long/short            Forward primer         Reverse primer      Product size/bp
  ---------------------- -------------------------- ------------------------ ---------------------- ---------------------- -----------------
  Alkaline phosphatase          NM_000478.4                   Long            CCACGTCTTCACATTTGGTG   AGACTGCGCCTGGTAGTTGT         196
  Short                     CCCGTGGCAACTCTATCTTT     CATGGAGACATTCTCTCGTTCA           131                                  
  Osteopontin                     J04765.1                    Long            CCCACAGACCCTTCCAAGTA   ACACTATCACCTCGGCCATC         279
  Short                     ACAGCCAGGACTCCATTGAC      GGGGACAACTGGAGTGAAAA            161                                  
  Osteonectin                     M25746.1                    Long            CTCTTTAACCCTCCCCTTCG   ATGGGCAAAGCTACAAATGG         230
  Short                     TGGATGGTTTGTTGTTCTGC     GGGACTATTAATGCGTGTGGA            153                                  
  Collagen I                    NM_000089.3                   Long            CTGCAAGAACAGCATTGCAT   GGCGTGATGGCTTATTTGTT         203
  Short                     ATGAGGAGACTGGCAACCTG     CAATGATTGTCTTTCCCCATT            150                                  
  Collagen III                  NM_000090.3                   Long            TACGGCAATCCTGAACTTCC   GTGTGTTTCGTGCAACCATC         245
  Short                     CATCTGGCATTCCTTCGACT     TGCTATTTCCTTCAGCCTTGA            163                                  
  Cbfa1/Runx2                  NM_001024630.3                 Long            TATGGAGTGCTGCTGGTCTG   TCTGGCCTTCCACTCTCAGT         280
  Short                     CACTCTGGCTTTGGGAAGAG      GCAGTTCCCAAGCATTTCAT            181                                  
  PPAR-γ                        NM_138712.3                   Long            GCTGTGCAGGAGATCACAGA   GGGCTCCATAAAGTCACCAA         225
  Short                     GCCAAAAGCATTCCTGGTT       TCCCTTGTCATGAAGCCTTG            155                                  
  LPL                           NM_000237.2                   Long            GGGCATGTTGACATTTACCC   AGCCCTTTCTCAAAGGCTTC         221
  Short                     CAGCCAGGATGTAACATTGG      TGGAACTGCACCTGTAGGC             163                                  
  ACAN                          NM_001135.3                   Long            GTGGAATGCAGAGGTGGTTT   ACAGCTGGGGACATTAGTGG         189
  Short                     AATCTTCTCTGCTGGCCTCA      GCTCCCTGGGTCTGGAGTAG            116                                  
  GAPDH                          NM_002046                    Long            CCTGACCTGCCGTCTAGAAA   TACTCCTTGGAGGCCATGTG         276
  Short                     TCAAGAAGGTGGTGAAGCAG      CCCTGTTGCTGTAGCCAAAT            198                                  

ACAN, aggrecan; Cbfa1/Runx2, Runt-related transcription factor 2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LPL, lipoproteinlipase; PCR, polymerase chain reaction; PPAR-γ, peroxisome proliferator-activated receptor gamma.
